Immucell (ICCC) Earnings Report, Financial Results, Financial analysis

Immucell Corp increased third quarter of 2023 net loss per share of $-0.12 compare to net loss per share of $-0.08 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.18 realized in previous quarter.

*third quarter of 2023*
Earnings Per Share	Revenues
$ -0.12	$ 5 Mill
$-0.04	Unch. +9.82 %

Immucell's Revenue rose by 9.82 % in third quarter of 2023 (Sep 30 2023) year on year, to $5 million and advanced by 73.03 % sequentially.

Immucell is Expected to report next financial results on March 28, 2024.

More on ICCC's Income Statement

ICCC's NET INCOME

Immucell's in thethird quarter of 2023 recorded net loss of $-0.940 million, an increase from net loss of $-0.655 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-1.380 million realized in previous quarter.

More on ICCC's Growth

Immucell Inventories
Inventories grew by 38.89 % to $7 million from III. Quarter a year ago, sequentially inventories fell by -1.99 %. ICCC's Cash flow In thethird quarter of 2023 company's net cash flow was $1 million, capital expenditures grew by -27.05%, to $-1 millions compare to same quarter a year ago and rose by -24.40% from II. Quarter (Jun 30 2023).

More on ICCC's Cash flow Statement

Earnings quality

Immucell Corp does not pay out common stock dividend.

In trailing twelve-month period Immucell Corp payed $ -0.68 cash per share, on a free-cash flow basis .

Book value fell by -3.14 % sequentially to $3.36 per share, -13.36% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.34 per share from $ 3.45.

Company repurchased 0.00 million shares or 0.00 % in Sep 30 2023.

• More on ICCC's Dividends

Market Capitalization (Millions)	35
Shares Outstanding (Millions)	8
Total Debt (Millions $)	12
Revenue (TTM) (Millions $)	16
Net Income (TTM) (Millions $)	-6
Cash Flow (TTM) (Millions $)	-7
Capital Exp. (TTM) (Millions $)	-3
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Immucell Corp does not pay out common stock dividend.

In trailing twelve-month period Immucell Corp had negative $ -0.68 cash flow per share, on a free-cash flow basis .

Book value fell by -3.14 % sequentially to $3.36 per share, -13.36% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.34 per share from $ 3.45.

Company repurchased 0.00 million shares or 0.00 % in Sep 30 2023.

• More on ICCC's Balance Sheets

Market Capitalization (Millions)	35
Shares Outstanding (Millions)	8
Total Debt (Millions $)	12
Revenue (TTM) (Millions $)	16
Net Income (TTM) (Millions $)	-6
Cash Flow (TTM) (Millions $)	-7
Capital Exp. (TTM) (Millions $)	-3
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Immucell Corp

ICCC's Financial Statements and Analysis